COMP <GO>
BCPC vs CE // RETURN ON INVESTED CAPITAL (ROIC)
Balchem Corporation (NASDAQ) VS. Celanese Corporation (NYSE) • 15-METRIC TALLY: BCPC 9
— CE 3
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: BCPC
LAST: $169.98 (-0.25%) • MKT CAP: $5.41B
roic
14.00%
LAST: $49.30 (+2.03%) • MKT CAP: $5.30B
roic
-10.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BCPC VS. CE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BCPC | CE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.70% | 20.50% | +15.20 | BCPC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 14.00% | -10.70% | +24.70 | BCPC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.5x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.00% | 15.14% | -11.14 | CE | /fcf-yield <GO> |
| Operating Margin | 20.20% | -8.20% | +28.40 | BCPC | /operating-margins <GO> |
| Net Profit Margin | 14.90% | -12.20% | +27.10 | BCPC | /net-margins <GO> |
| Revenue Growth (YoY) | 8.80% | -7.10% | +15.90 | BCPC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.52% | 0.25% | +0.27 | BCPC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.67 | 1.37 | +8.30 | BCPC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | BCPC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.3 | 57.7 | -6.40 | CE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.16 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.6x | 29.0x | +3.60 | CE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.41B | $5.30B | $111.8M | BCPC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BCPC REV | CE REV | BCPC GROSS % | CE GROSS % | BCPC FCF | CE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.04B | $9.54B | 35.7% | 20.5% | $216.6M | $803.0M |
| FY 2024 | $953.7M | $10.27B | 35.3% | 22.8% | $182.0M | $531.0M |
| FY 2023 | $922.4M | $10.93B | — | — | $183.8M | $1.41B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BCPC // BETA —
CE // BETA 1.16